510(k) K180835

SEKURE Acetaminophen L3K Assay by Sekisui Diagnostics P.E.I., Inc. — Product Code LDP

K180835 is an FDA 510(k) premarket notification submitted by Sekisui Diagnostics P.E.I., Inc. for the device "SEKURE Acetaminophen L3K Assay". The FDA issued a decision of Substantially Equivalent on Feb 8, 2019. The device falls under product code LDP (Colorimetry, Acetaminophen), a Class II device regulated under 21 CFR 862.3030. Sekisui Diagnostics P.E.I., Inc. has 5 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Feb 8, 2019
Date Received
Mar 30, 2018
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Colorimetry, Acetaminophen
Device Class
Class II
Regulation Number
862.3030
Review Panel
TX
Submission Type
510(k)

Need the full FDA record for Sekisui Diagnostics P.E.I., Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K180835. Report a data issue: hello@regdatalab.com.